Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Expert Opinion on Drug Delivery|December 24, 2005
Bacterial ghosts as a novel advanced targeting system for drug and DNA deliverySusanne Paukner, Thomas Stiedl, Pavol Kudela, et al.Antimicrobial Agents and Chemotherapy|January 11, 2012
Antimicrobial activity of the investigational pleuromutilin compound BC-3781 tested against Gram-positive organisms commonly associated with acute bacterial skin and skin structure infectionsHelio S Sader, Douglas J Biedenbach, Susanne Paukner, et al.Journal of Clinical Microbiology|July 21, 2012
Disk diffusion and MIC quality control ranges for BC-3205 and BC-3781, two novel pleuromutilin antibioticsJames E Ross, Helio S Sader, Zrinka Ivezic-Schoenfeld, et al.Antimicrobial Agents and Chemotherapy|January 24, 2019
Antibacterial Activity of Lefamulin against Pathogens Most Commonly Causing Community-Acquired Bacterial Pneumonia: SENTRY Antimicrobial Surveillance Program (2015-2016)Susanne Paukner, Steven P Gelone, S J Ryan Arends, et al.Antibiotics (Basel, Switzerland)|November 27, 2021
Determination of In Vitro Antimicrobial Susceptibility for Lefamulin (Pleuromutilin) for Ureaplasma Spp. and Mycoplasma hominisOliver Spiller-Boulter, Susanne Paukner, Ian Boostrom, et al.Plos One|September 29, 2021
Anti-inflammatory activity of lefamulin versus azithromycin and dexamethasone in vivo and in vitro in a lipopolysaccharide-induced lung neutrophilia mouse modelMichael Hafner, Susanne Paukner, Wolfgang W Wicha, et al.Antimicrobial Agents and Chemotherapy|November 18, 2016
In Vitro Activities of Lefamulin and Other Antimicrobial Agents against Macrolide-Susceptible and Macrolide-Resistant Mycoplasma pneumoniae from the United States, Europe, and ChinaKen B Waites, Donna M Crabb, Lynn B Duffy, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2004
Bacterial ghosts are an efficient delivery system for DNA vaccinesThomas Ebensen, Susanne Paukner, Claudia Link, et al.BMC Pulmonary Medicine|May 9, 2021
Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbiditiesThomas M File, Elizabeth Alexander, Lisa Goldberg, et al.Antimicrobial Agents and Chemotherapy|January 24, 2019
Low Prevalence of Gram-Positive Isolates Showing Elevated Lefamulin MIC Results during the SENTRY Surveillance Program for 2015-2016 and Characterization of Resistance MechanismsRodrigo E Mendes, Susanne Paukner, Timothy B Doyle, et al.Pageof 4